Wednesday, November 16, 2011
Understanding Patients in the Emerging Market of Brazil
Date Posted: 11/10/2011
Size: 6.89MB
Length: 00:15:03
Thought Leader: David Pomerantz, Senior Vice President, Business Development, Kantar Health
In this episode, Mr. Pomerantz talks about the influence of patients in pharma and especially in emerging markets such as Brazil.
Play Podcast
Size: 6.89MB
Length: 00:15:03
Thought Leader: David Pomerantz, Senior Vice President, Business Development, Kantar Health
In this episode, Mr. Pomerantz talks about the influence of patients in pharma and especially in emerging markets such as Brazil.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Planning for Clinical Trial Conduct in Emerging Locations
Date Posted: 9/28/2011
Size: 6.4MB
Length: 00:14:07
Thought Leader: Kelly Larrabee, RN, MBA, MS, Senior Director, Clinical Services, ClearTrial
In this episode Ms. Larrabee discusses clinical trials in emerging countries, and the major planning challenges, plus how collaborative partnerships are helping in the search for new treatments. For more information about ClearTrial, visit http://www.cleartrial.com/.
Play Podcast
Size: 6.4MB
Length: 00:14:07
Thought Leader: Kelly Larrabee, RN, MBA, MS, Senior Director, Clinical Services, ClearTrial
In this episode Ms. Larrabee discusses clinical trials in emerging countries, and the major planning challenges, plus how collaborative partnerships are helping in the search for new treatments. For more information about ClearTrial, visit http://www.cleartrial.com/.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Keys to Partnering with a Pharmaceutical Call Center
Date Posted: 9/13/2011
Size: 4.67MB
Length: 00:10:13
Thought Leader: Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brand
In this episode, Mr. Shapiro shares his views on how pharmaceutical, biotech, and medical device companies can benefit from partnering with a qualified pharmaceutical call center. For more information about PhoneScreen, visit http://www.phonescreen.com/.
Play Podcast
Size: 4.67MB
Length: 00:10:13
Thought Leader: Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brand
In this episode, Mr. Shapiro shares his views on how pharmaceutical, biotech, and medical device companies can benefit from partnering with a qualified pharmaceutical call center. For more information about PhoneScreen, visit http://www.phonescreen.com/.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Leveraging Customer Insights to Maximize ROI
Date Posted: 8/31/2011
Size: 6.17MB
Length: 00:13:29
Thought Leaders: Jay Bolling, President & CEO, Chuck McLeester, SVP Planning, Metrics & Analytics, Kurt Mueller, Chief Digital & Science Officer, Roska Healthcare Advertising
In this episode, the team at Roska Healthcare discusses new ways to use behavioral and attitudinal data to enhance customer targeting and messaging. They review a unique, new communications model (Catalyst-tm) that increases customer 'acceptance' (engagement) and drives more people to take action.
Play Podcast
Size: 6.17MB
Length: 00:13:29
Thought Leaders: Jay Bolling, President & CEO, Chuck McLeester, SVP Planning, Metrics & Analytics, Kurt Mueller, Chief Digital & Science Officer, Roska Healthcare Advertising
In this episode, the team at Roska Healthcare discusses new ways to use behavioral and attitudinal data to enhance customer targeting and messaging. They review a unique, new communications model (Catalyst-tm) that increases customer 'acceptance' (engagement) and drives more people to take action.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Mentoring: A Professional Advantage
Date Posted: 8/12/2011
Size: 6.17MB
Length: 00:13:29
Thought Leader: Laurie Cooke, CEO, Healthcare Businesswomen's Association
In this episode, Ms. Cooke discusses what it means to be honored as Mentor of the Year, why mentoring is an important career development strategy, and the HBA's commitment to helping its members develop their careers through mentoring and coaching.
Play Podcast
Size: 6.17MB
Length: 00:13:29
Thought Leader: Laurie Cooke, CEO, Healthcare Businesswomen's Association
In this episode, Ms. Cooke discusses what it means to be honored as Mentor of the Year, why mentoring is an important career development strategy, and the HBA's commitment to helping its members develop their careers through mentoring and coaching.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Understanding the Power of KOL Influence Mapping
Date Posted: 6/27/2011
Size: 6.37MB
Length: 00:13:55
Thought Leader: Gary Bartolacci, Senior Account Director, Kantar Health
In this episode, Mr. Bartolacci discusses the power of key opinion leaders nationally, regionally, and locally. He explains how pharmaceutical companies can achieve stronger results using influence mapping, various approaches to influence mapping (including the benefits and risks of these studies) and best practices, along with addressing clients' most common questions.
Play Podcast
Size: 6.37MB
Length: 00:13:55
Thought Leader: Gary Bartolacci, Senior Account Director, Kantar Health
In this episode, Mr. Bartolacci discusses the power of key opinion leaders nationally, regionally, and locally. He explains how pharmaceutical companies can achieve stronger results using influence mapping, various approaches to influence mapping (including the benefits and risks of these studies) and best practices, along with addressing clients' most common questions.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Clinical Supply Optimization: Challenges & Solutions
Date Posted: 5/31/2011
Size: 7.8MB
Length: 00:17:03
Thought Leader: Steven Yoder, Director, Client Services, Fisher Clinical Services
In this episode, Mr. Yoder discusses the challenges and benefits of clinical supply optimization and what the future looks like as companies strive to achieve a balance between optimization and cost-reduction.
Play Podcast
Size: 7.8MB
Length: 00:17:03
Thought Leader: Steven Yoder, Director, Client Services, Fisher Clinical Services
In this episode, Mr. Yoder discusses the challenges and benefits of clinical supply optimization and what the future looks like as companies strive to achieve a balance between optimization and cost-reduction.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Networked Drug Development - Bringing Assets, Capital and Services Together
Date Posted: 5/31/2011
Size: 5.56MB
Length: 00:12:09
Thought Leader: Tim Dietlin, VP of Alliance Development, INC Research
In this episode, Mr. Dietlin discusses a burgeoning concept called the Networked Drug Development Alliance, what it is, what's driving it, and how they improve the process for pharmaceutical companies and investors.
Play Podcast
Size: 5.56MB
Length: 00:12:09
Thought Leader: Tim Dietlin, VP of Alliance Development, INC Research
In this episode, Mr. Dietlin discusses a burgeoning concept called the Networked Drug Development Alliance, what it is, what's driving it, and how they improve the process for pharmaceutical companies and investors.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Improving Safety, Security, and Speed using Voice Biometrics
Date Posted: 4/29/2011
Size: 7.95MB
Length: 00:17:23
Thought Leader: Richard Scarbath , Director, Enterprise Accounts, Angel
In this episode, Mr. Scarbath discusses the movement into voice biometrics for voice signatures and authentication. He provides a general overview of the technology and how it is being applied in the pharmaceutical industry and sampling world..
Play Podcast
Size: 7.95MB
Length: 00:17:23
Thought Leader: Richard Scarbath , Director, Enterprise Accounts, Angel
In this episode, Mr. Scarbath discusses the movement into voice biometrics for voice signatures and authentication. He provides a general overview of the technology and how it is being applied in the pharmaceutical industry and sampling world..
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
The Undercalculated Costs Driving Today's Clinical Trials
Date Posted: 4/29/2011
Size: 12.0MB
Length: 00:26:17
Thought Leader: Ian Hunter, Global Account Director, Fisher Clinical Services
In this episode, Mr. Hunter, discusses the many variables and issues surrounding transportation and distribution of product for global clinical trials.
Play Podcast
Size: 12.0MB
Length: 00:26:17
Thought Leader: Ian Hunter, Global Account Director, Fisher Clinical Services
In this episode, Mr. Hunter, discusses the many variables and issues surrounding transportation and distribution of product for global clinical trials.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, April 07, 2011
Oncology Trials: A Novel Approach to Patient Accrual
Date Posted: 3/30/2011
Size: 5.95MB
Length: 00:13:02
Thought Leader: Ed Watson, Director of Oncology, Acurian, Inc.
In this episode, Ed Watson discusses some of the challenges associated with recruiting for clinical studies in oncology, the roles of various key stakeholders, and the sponsor community's response to a new approach to patient accrual.
Size: 5.95MB
Length: 00:13:02
Thought Leader: Ed Watson, Director of Oncology, Acurian, Inc.
In this episode, Ed Watson discusses some of the challenges associated with recruiting for clinical studies in oncology, the roles of various key stakeholders, and the sponsor community's response to a new approach to patient accrual.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Streamlining Clinical Trials with an Approved Phrase Library for Labeling
Date Posted: 3/24/2011
Size: 7.68MB
Length: 00:16:32Thought Leader: Kevin Shea, Label Program Director, Clintrak Clinical Labeling Services LLC., a part of Thermo Fisher Scientific
In this episode, Mr. Shea discusses how clinical trials are affected by label text issues, streamlining the process with a phrase library, and the advantages of managing a phrase library with a dedicated system.
Size: 7.68MB
Length: 00:16:32Thought Leader: Kevin Shea, Label Program Director, Clintrak Clinical Labeling Services LLC., a part of Thermo Fisher Scientific
In this episode, Mr. Shea discusses how clinical trials are affected by label text issues, streamlining the process with a phrase library, and the advantages of managing a phrase library with a dedicated system.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Why ISMPP?: Leadership, Value, and Best Practices for Medical Publication Professionals
Date Posted: 3/4/2011
Size: 6.78MB
Length: 00:14:49
Thought Leaders: Kim Goldin, Executive Director, Julia Ralston, President, and Robert Norris, Past President, ISMPP
In this episode, our thought leaders discuss what ISMPP is and how it's evolved, how the organization can help Medical Publication Professionals, and the 2011 annual meetings in the US in April and in Europe in November.
Size: 6.78MB
Length: 00:14:49
Thought Leaders: Kim Goldin, Executive Director, Julia Ralston, President, and Robert Norris, Past President, ISMPP
In this episode, our thought leaders discuss what ISMPP is and how it's evolved, how the organization can help Medical Publication Professionals, and the 2011 annual meetings in the US in April and in Europe in November.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Building a Communications Bridge: A Best Practice for Conducting Clinical Trials in India
Date Posted: 3/1/2011
Size: 7.4MB
Length: 00:16:10
Thought Leaders: Dr. James A. Bannon, Executive Chairman and Dr. Edward J. Brennan, Jr. President and CEO, IndiPharm
In this episode, Dr. Bannon and Dr. Brennan discuss conducting clinical trials in India. They cover why a seamless communication strategy is important, how an in-country partner can improve the trial outcome, regulatory issues in India, and the ROI of conducting clinical trials in India.
Size: 7.4MB
Length: 00:16:10
Thought Leaders: Dr. James A. Bannon, Executive Chairman and Dr. Edward J. Brennan, Jr. President and CEO, IndiPharm
In this episode, Dr. Bannon and Dr. Brennan discuss conducting clinical trials in India. They cover why a seamless communication strategy is important, how an in-country partner can improve the trial outcome, regulatory issues in India, and the ROI of conducting clinical trials in India.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
A New Wellness-Centric Ecosystem
Date Posted: 1/31/2011
Size: 4.63MB
Length: 00:10:07
Thought Leaders: Nagaraja Srivatsan, Senior VP and Head of Life Sciences, North America and Dr. Elby Nash, Principal, Cognizant Business Consulting, Life Sciences, Cognizant
In this episode, Srivatsan and Dr. Nash discuss a forward-thinking business model that focuses on overall patient wellness and preventative medicine rather than simply treating illness.
Size: 4.63MB
Length: 00:10:07
Thought Leaders: Nagaraja Srivatsan, Senior VP and Head of Life Sciences, North America and Dr. Elby Nash, Principal, Cognizant Business Consulting, Life Sciences, Cognizant
In this episode, Srivatsan and Dr. Nash discuss a forward-thinking business model that focuses on overall patient wellness and preventative medicine rather than simply treating illness.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Best Practices for Your CRO Partnerships
Date Posted: 1/31/2011
Size: 8.04MB
Length: 00:17:34
Thought Leader: Colin Terry, Executive Vice President, Commercial Operations, Aptuit
In this episode, Mr. Terry shares his perspective on how drug developers can move beyond the typical, transactional, approach to outsourcing and instead, create true partnerships with their CROs that reflect a commitment to a shared development vision.
Size: 8.04MB
Length: 00:17:34
Thought Leader: Colin Terry, Executive Vice President, Commercial Operations, Aptuit
In this episode, Mr. Terry shares his perspective on how drug developers can move beyond the typical, transactional, approach to outsourcing and instead, create true partnerships with their CROs that reflect a commitment to a shared development vision.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
How Integrated Solutions Can Optimize Clinical Research
Date Posted: 1/31/2011
Size: 5.97MB
Length: 00:13:03
Thought Leader: James DeSanti, CEO, PharmaVigilant
In this episode, Mr. DeSanti discusses Integrated Solutions in clinical research. We define the concept, outline how sponsors can utilize it, and finally, we cover the benefits and ROI of an integrated approach.
Size: 5.97MB
Length: 00:13:03
Thought Leader: James DeSanti, CEO, PharmaVigilant
In this episode, Mr. DeSanti discusses Integrated Solutions in clinical research. We define the concept, outline how sponsors can utilize it, and finally, we cover the benefits and ROI of an integrated approach.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Unveiling the Potential of the CEE Market
Date Posted: 1/31/2011
Size: 8.78MB
Length: 00:19:11
Thought Leader: Pali F. Kollath DVM, MBA Regional Director, Central & Eastern Europe and Treatment Value Practice, Kantar Health
In this episode, Pali F. Kollath discusses Central and Eastern Europe as an emerging market for pharmaceutical companies. You'll learn how large this market is, the benefits of moving into this market, some of the risks and challenges, best practices for setting up operations, and where the market is heading in the future.
Size: 8.78MB
Length: 00:19:11
Thought Leader: Pali F. Kollath DVM, MBA Regional Director, Central & Eastern Europe and Treatment Value Practice, Kantar Health
In this episode, Pali F. Kollath discusses Central and Eastern Europe as an emerging market for pharmaceutical companies. You'll learn how large this market is, the benefits of moving into this market, some of the risks and challenges, best practices for setting up operations, and where the market is heading in the future.
Download transcript and white paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, January 04, 2011
China: An Emerging Market for Cancer Therapeutics
Date Posted: 12/30/2010
Size: 6.12MB
Length: 00:13:48
Thought Leader: Richard Wagner, Ph.D., Senior Director, Kantar Health
In this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar's latest research on cancer in China.
Size: 6.12MB
Length: 00:13:48
Thought Leader: Richard Wagner, Ph.D., Senior Director, Kantar Health
In this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar's latest research on cancer in China.
Download transcript and white paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Subscribe to:
Posts (Atom)